Berndt Modig insider trades

Open-market stock purchases and sales by Berndt Modig, Chief Executive Officer at Pharvaris NV, from SEC Form 4 filings since Apr 29, 2016.

Recent trades

DateStockTradeValue
Sep 17, 2026PHVS Pharvaris NVSold (not open market)$10.5M
Sep 14, 2026PHVS Pharvaris NVSold$90.3K
Aug 14, 2026PHVS Pharvaris NVSold$79.7K
Jul 13, 2026PHVS Pharvaris NVSold$80.2K
Jun 15, 2026PHVS Pharvaris NVSold$68K
Jun 15, 2026PHVS Pharvaris NVSold$3.1K
May 18, 2026PHVS Pharvaris NVSold$67K
Apr 16, 2026PHVS Pharvaris NVSold$65.6K
Apr 9, 2026PHVS Pharvaris NVSold$642K
Apr 9, 2026PHVS Pharvaris NVSold$5.7K

Companies traded

  • PHVS Pharvaris NV: 9 sales, last Sep 17, 2026
  • SIOX Sio Gene Therapies Inc: other filings, last Apr 15, 2021
  • AXGT Axovant Gene Therapies Ltd: other filings, last Apr 15, 2020
  • AXON Axovant Sciences Ltd: other filings, last Mar 15, 2018

Get free alerts when Berndt Modig files a new trade →